On Saturday, April 5, The Bernie Mac Foundation will hold its eighth annual Purple Carpet Fundraiser at the Orland Chateau in ...

Dr. Jad Kebbe, a pulmonologist at the University of Oklahoma Health Sciences Center, discusses the risks of inhaling wildfire ...

Key findings • Sarcoidosis patients are prone to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, increased severity, morbidity and greater mortality of coronavirus disease 2019 ...

With $75.1 million in cash and minimal competition, aTyr Pharma is well-positioned financially, making it a compelling high-risk, high-reward investment. Read more on ATYR stock here.

Xentria, a clinical-stage biopharmaceutical company advancing therapies for rare and serious diseases, today announced the successful completion of enrollment in the therapeutic dose-ranging phase of ...

Couple main things to keep in mind would be pulmonary fibrosis or sarcoidosis, which can have very long-term effect and damage to people's lung health and health in general." Q: What is ...

Xentria's milestone advances XTMAB-16, a potential therapy for this inflammatory disorder with limited treatment options "This marks a significant step forward for the sarcoidosis community ...

Hiring Dalia Rayes as head of commercial for the global efzofitimod franchise slots another piece of the puzzle into place.